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ABSTRACT
eIF4E binding protein (4E-BP) inhibits translation of
capped mRNA by binding to the initiation factor
eIF4E and is known to be mostly or completely
unstructured in both free and bound states. Using
small angle X-ray scattering (SAXS), we report here
the analysis of 4E-BP structure in solution, which
reveals that while 4E-BP is intrinsically disordered
in the free state, it undergoes a dramatic compac-
tion in the bound state. Our results demonstrate that
4E-BP and eIF4E form a ‘fuzzy complex’, challenging
current visions of eIF4E/4E-BP complex regulation.
INTRODUCTION
Translation is a complex process that is critical for gene
regulation during development, differentiation, nervous
system function, aging and disease. In eukaryotes, trans-
lation of mRNA begins with speciﬁc recognition of the
50-cap structure by the highly conserved eukaryotic
Initiation Factor 4E, eIF4E, a master switch in translation
initiation that participates in recruiting mRNAs to the
ribosome (1). This cap-dependent initiation process is
mainly regulated by the eIF4E binding protein (4E-BP),
a small protein of  13kDa, which plays the role of an
important repressor of translation.
4E-BP is known to prevent the association of eIF4E
with the large scaffolding protein eIF4G that acts as a
docking site for several proteins required to bridge the
ribosome and the mRNA. 4E-BP shares with eIF4G the
eIF4E-binding motif YXXXXL (where X is any amino
acid and  is a hydrophobic residue) (2) that interacts
with the convex dorsal surface of eIF4E. Binding of
4E-BP to eIF4E is classically described as resulting from
the interaction between the 4E-BP central consensus motif
and eIF4E, which is dependent upon the phosphorylation
status of 4E-BP (3,4). Nevertheless, the regulation of the
association/dissociation (5) as well as the molecular mech-
anisms occurring during eIF4E/4E-BP complex formation
are not fully understood yet, even if eIF4E and its repres-
sor 4E-BP are to date some of the most characterized
chemically and biophysically cap-dependent initiation
factors. A new structural study of the eIF4E/4E-BP
complex is therefore important to better understand the
regulation of cap-dependent initiation.
Previous high-resolution X-ray crystallography revealed
that the eIF4E recognition motif contained in the 4E-BP1
peptide (residues 51–67) undergoes a folded transition
upon binding to eIF4E forming an L-shaped structure
consisting of an extended chain region and a short
a-helix (6). Until now, the unfolded nature of 4E-BP
outside of the central peptide has been an obstacle for
conventional structural methods and consequently no
structure of the eIF4E/4E-BP full length complex has
been obtained. Nuclear magnetic resonance (NMR)
approaches have concluded in a mostly or completely un-
structured 4E-BP1 in both free and bound states (7), and
have shown in a very indirect manner that the binding
footprint of 4E-BP on eIF4E might be larger than the
one established by crystallography (8). Nevertheless, it is
generally considered that only the central peptide of
4E-BP plays a major role in the eIF4E/4E-BP complex
formation, and that consequently, ﬂexible sections that
ﬂank the central peptide of 4E-BP do not.
Interestingly, recent data showed that 4E-BP, unlike
eIF4G, is still able to interact with eIF4E when the
eIF4E-binding site is occupied by the small pharmacologic
compound 4EGi-1 (for eIF4E/eIF4G interaction inhibi-
tor) (9). These data are difﬁcult to integrate if 4E-BP
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Therefore, since this statement is in contradiction with
biochemical data (9) and the eIF4E/4E-BP complex for-
mation remains not well understood, we decided to recon-
sider the folding status of 4E-BP associated with eIF4E.
We applied the appropriate and increasingly used method
for the structural analysis in solution, namely small angles
X-ray scattering (SAXS). SAXS has proven to be a fun-
damental tool for the study of biological molecules in
solution (10–13). The originality of this method lies in
the fact that it can provide structural information on
molecules exhibiting some intrinsic disorder, ﬂexibility or
heterogeneity, which usually constitutes a major obstacle
for the other classical structural methods. Applying
this technique to study the eIF4E/4E-BP complex, we
observed for the ﬁrst time the entire structure at low reso-
lution of the complex eIF4E/full-length 4E-BP and show
a dramatic compaction of 4E-BP while it interacts with
eIF4E. The combination of our results to other previous
structural analysis, allowed us to build a new model of
interaction, involving a much larger binding footprint of
4E-BP on eIF4E.
MATERIALS AND METHODS
Proteins expression and puriﬁcation
The construction of the plasmid pAr encoding eIF4E1
from mus musculus has already been described (14) and
the protocol to produce and purify eIF4E1 tagged FLAG
was performed as described herein. The cloning of
Strongylocentrotus purpuratus Sp4E-BP was performed
using a S. purpuratus cDNA library. The 342-bp
fragment corresponding to the Sp4E-BP coding region
was ampliﬁed by PCR and inserted into the pFO4
vector digested with BamH1 and EcoR1. 4E-BP, with an
Histidine tag, was overexpressed in the BL21 (DE3) strain
Escherichia coli (Novagen). Cellular pellet from bacteria
were resuspended in 5 volumes buffer A (50mM sodium
phosphate, 300mM NaCl, 80mM imidazole, pH 8). Cells
were lysed using French Press with an amplitude of 1.6.
The lysate was then incubated 30min at 4 C with 1%
Triton (Sigma) and clariﬁed by centrifugation at 10000g
for 30min. The clariﬁed supernatant was then injected
on an afﬁnity column, packed with a chelating sepharose
Fast Flow Resin preloaded with Ni
2+ ions (Amersham
Pharmacia Biotech), previously equilibrated with buffer
A. The column was washed with buffer A and the
protein was eluted with a gradient of imidazole from 80
to 500mM. Eluates were analyzed by SDS–PAGE for the
presence of the desired product. The fractions containing
the recombinant product were combined, and concent-
rated using Amicon Ultra-4 Centrifugal Filter Units
(10kDa). The protein was then loaded onto a Superdex
75 column (Amersham Pharmacia Biotech) and eluted in
buffer C (50mM Phosphate, 300mM NaCl, pH 8). The
proteins were concentrated with Amicon Ultra-4
Centrifugal Filter Units (10kDa) and the concentration
of the puriﬁed proteins was estimated with a Nanodrop
ND-1000.
After production and puriﬁcation, 1.5mg of eIF4E1
was incubated for 1h with 500mlo fm
7GTP sepharose
beads (Amersham Pharmacia Biolabs) in buffer CAP
(50mM HEPES, 150mM KCl, 1mM EDTA, 5%
glycerol, pH 7.7). After washing, the beads were incubated
for 1h in buffer CAP containing 1mg/ml of BSA, 0.5%
Igepal with 4mg of 4E-BP. After extensive washing, the
complex was eluted from the afﬁnity column with 200mM
of free m
7GTP in buffer CAP. After concentration with
Amicon Ultra-4 Centrifugal Filter Units (10kDa), the
complex was then loaded onto a Superdex 75 column
(Amersham Pharmacia Biotech) and eluted in buffer
CAP. The peak containing the complex was concentrated
with an Amicon Ultra-4 Centrifugal Filter Units
(10kDa). The quality of the puriﬁed proteins was
analyzed by SDS–PAGE (Supplementary Figure S1). As
expected we observed two bands with the sample contain-
ing the complex of eIF4E and 4E-BP. Quantiﬁcation with
the image analysis software ImageQuant reveals a ratio of
2.1 between the two bands corresponding, respectively, to
eIF4E and 4E-BP, consistent with a stoichiometry ratio of
1:1 since 4E-BP is two times smaller than eIF4E.
SAXS experiments
SAXS experiments were carried out twice on the beamline
ID14-3 at the European Synchrotron facility (ESRF),
Grenoble, France and on the beamline X33 at the
DORIS-III storage ring at DESY (Deutsches
Elektronen-Synchrotron), Hamburg, Germany. Data
have been treated on both beamlines, showing essentially
the same results. However, the higher brilliance of the
beam at the ESRF consequently was more suitable for
analyzing our protein concentrations, which is why the
data shown here only come from the beamline ID14-3.
On ID14-3, the wavelength was 0.931A ˚ and the sample-
to-detector distance was 1.67m, leading to scattering
vectors q ranging from 0.1to 5nm
 1. Due to the low con-
centration of some of our samples ( 1mg/ml), the data
beyond 0.25 A ˚  1 were statistically not exploitable and
were therefore truncated in order to enhance the analysis
quality. The scattering vector is deﬁned as q=4p/  sin y,
where 2y is the scattering angle. The detector used was
an X-ray detector Pilatus 1M from Dectris coupled to a
CCD camera and 10 successive frames of 10 s exposure
time were recorded for each sample. Each frame was care-
fully checked for possible bubble formation or radiation-
induced aggregation. If such effects were not observed,
the individual frames were averaged. A 4.8mg/ml
solution of BSA was measured as a reference and for cali-
bration procedures. Up to ﬁve different concentrations
of each protein sample were measured to test for consist-
ency and eventually detect and eliminate concentration
dependent effects. Background scattering was quantiﬁed
before and after each protein measurement by measuring
the corresponding buffer, which is then subtracted
from the protein patterns using the Primus suite (15).
All experiments were performed at 16 C.
Data evaluation. For high concentrations of 4E-BP, the
experimental SAXS data were not linear in the Guinier
Nucleic Acids Research,2011, Vol.39, No. 8 3497plot of the low q region, indicating that the proteins
undergo aggregation. We only used the scattering proﬁle
for concentrations below 6mg/ml. The radius of gyration,
Rg, was derived by the Guinier approximation:
I(q)=I(0)exp( q
2Rg
2/3) up to qRg<1.0. The radii of
gyration, Rg, calculated for different 4E-BP concentra-
tions display concentration dependence at high concentra-
tion, indicating the presence of attractive interactions
of the particles in solution. The Rg was approximated
for a theoretical concentration of 0mg/ml. The Rg
calculated for different complex eIF4E/4E-BP concentra-
tions display no concentration dependence and indicate
the absence of interaction in solution. The program
GNOM (16) was used to compute the pair-distance distri-
bution functions P(r). This approach gives the maximum
dimension of the macromolecule Dmax and offers an alter-
native calculation of Rg, which is based on the entire scat-
tering curve. Data evaluation for free eIF4E is reported in
the Supplementary Data.
Ab Initio modeling of the overall shapes. The overall
shapes of all assemblies were restored from the experi-
mental data by three independent programs (detailed in
Supplementary Data): DAMMIN, GASBOR and
DAMMIF (17). The scattering proﬁles were used up to
qmax=0.25A ˚  1. Nine low-resolution models obtained
from different runs were compared using the program
DAMAVER (18) to give an estimate of the reproducibility
of the results inferred from the ab initio shape calculation
and to construct the average model representing the gen-
eral structural features of all the reconstruction ﬁltered by
DAMFILT.
The ‘drag’ option of the program Pymol (The PyMOL
Molecular Graphics System, Version 1.2r3pre,
Schro ¨ dinger, LLC) was then used to position manually
the crystal structure of eIF4E (19) into the low-resolution
envelope of eIF4E obtained by SAXS measurements
(Supplementary Figure S2). The same method was
applied to position the crystal structure of the complex
eIF4E/ 4E-BP peptide (20) into the low-resolution
envelope of the complex eIF4E/4E-BP, respectively
(Figure 2c). To establish this crystal structure, Tomoo
et al. (20) used a 4E-BP peptide containing the amino
acids from 36 to 70 but only the residues 47–66 are ﬁnally
present in the structure because they were the only ones
visible on the electron density. The Protein Data Bank
accession codes for eIF4E and eIF4E/4E-BP peptide
crystal structures are respectively 1L8B and 1WKW.
These structural superimpositions of the partial crystal
structures and the low resolution solution structures
obtained by SAXS measurements demonstrate that the
overall shape of the eIF4E/4E-BP complex does not
coincide with the shape of eIF4E free in solution but
clearly results from the association of 4E-BP and eIF4E.
The goodness of ﬁt for all atomic models, as well as the
low resolution models, was determined using the  
2 dis-
crepancy (15) reported in the experimental data (Table 1).
Construction of the structural model of 4E-BP embracing
eIF4E—construction of the structural model of 4E-BP
embracing eIF4E. The residues of yeast eIF4E that were
affected by the binding of 4E-BP have been identiﬁed by
NMR titration measurements in ref. (8). We have
transferred these residues onto eIF4E1 crystal structure
from mouse by structural superimposition of the respect-
ive three-dimensional (3D) structures. Since no speciﬁc
secondary or tertiary structuration of 4E-BP is assumed
within the fuzzy complex, the most extended residue con-
formation (i.e. b-strand) was chosen to mimic the intrin-
sically unstructured ‘arms’ of 4E-BP. Consequently,
starting from the crystal structure of eIF4E in complex
with the 4E-BP1 peptide (20), the according N- and
C-terminal residues were sequentially added to the
central 4E-BP peptide with standard extended b-strand
conformation following the residues on eIF4E that were
affected by 4E-BP binding, using the interactive graphical
software TURBO (21). Residues were added, covering the
external surface of eIF4E, until ‘free dangling’ ends of
4E-BP were produced. The ending residues were chosen
arbitrarily to be situated ﬁve residues beyond the surface
Table 1. Experimental and model SAXS parameters
Proteins Exp. I(0)
a Conc.
(mg/ml)
b
Estimated
Mr (kDa)
c
Mr
d
(kDa)
Number of
amino acids
Rg (GNOM)
e Rg (Guinier)
e Dmax
f (nm) V
(over) V
(crysol) Damaver
NSD
g
4E-BP 4883 1.86 20 12.8 117 4.86±0.22 4.88±0.17 16.0±0.8 0.430 NA 2.50 ± 0.14
eIF4E 4256 1.26 26.6 25.05 217 2.34±0.11 2.23±0.44 6.8±0.6 0.433 1364 ND
eIF4E/4E-BP
Complex
5922 1.11 41.9 37.058 334 3.60±0.03 3.52±0.04 12.1±0.6 1.360 NA 1.40 ± 0.08
BSA 40247 4.8 66.3 582 ND 3.1±0.2 9.0±0.4 ND ND ND
aValues for I(0) have been extrapolated by the Guinier approximation from the experimental scattering proﬁles.
bConcentration of the protein used for the calculation of the estimated Mr.
cRelative molecular mass estimated from I(0) and the concentration of the protein through BSA calibration.
dRelative molecular mass predicted from the sequence.
eRg (Guinier), Rg (GNOM), radius of gyration given by the Guinier approximation, and calculated by the program GNOM, respectively, given in
nm.
fMaximum dimension of the macromolecules.
V
(over) Discrepancy between the SAXS proﬁle and its ﬁt by the overall shapes-models calculated by DAMMIF, and V
(crysol) the average discrepancy
of the best atomic models estimated with the program CRYSOL (Supplementary Data). ND, not determined; NA, not appropriate.
gAverage of the normalized spatial discrepancies (NSD) obtained by Damaver for the different ab initio models generated by DAMMIF, DAMMIN
and GASBOR.
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eIF4E was designed. Glycine residues are well known to
be involved in hinge regions. Considering that the central
binding peptide of 4E-BP is ﬂanked by two sequential
glycines (G38 and G39) on the N-terminal side and by
repeated glycines at positions 79, 86 and 88 on the
C-terminal side, these glycine residues were chosen to
perform rotational adjustments for the extended arms of
4E-BP to follow the external surface of eIF4E without
producing sterical clashes. Sterical clashes were evaluated
by distance–any atom of a residue was checked to be no
closer than 3.0A ˚ .
RESULTS
In our study, as a representative translational repressor,
we used the 4E-BP protein from the sea urchin (S.
purpuratus), a sister group to chordates (22), that has
only one 4E-BP. In vertebrates, the ancestral gene for
4E-BP underwent duplication giving rise to three 4E-BPs
(4E-BP1, 4E-BP2 and 4E-BP3) in mammals. Both
4E-binding motif and phosphorylation sites of 4E-BPs
are strongly conserved in distantly-related species (22) as
well as the entire sequence of the protein (Supplementary
Figure S5). Moreover, we previously conducted an exten-
sive functional analysis showing that variants mimicking
hyperphosphorylation of Sp 4E-BP and its mammalian
counterpart displayed similar properties (5). The wild-
type version of these proteins represses translation to a
similar extent when added in a mammalian reticulocyte
lysate (Supplementary Figure S4), indicating that Sp
4E-BP is functional to inhibit mammalian eIF4E.
Disorder predicted from the primary sequence
Intrinsically disordered protein prediction is a necessary
prerequisite for the complete understanding of protein
folding. Initially, we analyzed the primary sequence of
S. purpuratus 4E-BP (Sp 4E-BP, Supplementary
Figure S3) using various algorithms that predict disorder,
in order to localize consensus disordered regions as
described in ref. (23). This approach showed that 4E-BP
is a mostly intrinsically disordered protein. Only a short
central domain, containing the eIF4E-binding motif
(YDRNFLLM) that displayed a hydrophobic cluster, is
predicted to be structured. We observed the same pattern
for the human 4E-BP1 (data not shown). The central
domain predicted to be structured in our analysis corres-
ponds to the one that undergoes a folded transition in an
a-helix upon binding to eIF4E in the crystal structure
(6,20).
Solution structure of the free 4E-BP
To determine the solution structure of 4E-BP, we used
SAXS analysis. The 4E-BP scattering proﬁle (Figure 1a)
was obtained as described in Methods. The Krakty proﬁle
(Figure 1a, inset), derived from the scattering proﬁle, had
a plateau-shaped appearance typical of unfolded proteins
or extended molecules (24). Analysis of the scattering
curve for low q gave a radius of gyration (Rg)o f
4.88nm determined by the Guinier approximation,
suggesting that the protein possesses a very extended
state with a maximum distance of 16.0nm (Table 1). In
comparison, a typical globular protein of same molecular
mass, such as for example Neocarzinostatin (25), has a Rg
value of 1.4nm. The overall envelope of 4E-BP was
calculated ab initio from its scattering proﬁle using
DAMMIF and the most typical shape is provided
Figure 1b. The program DAMAVER allowed us to
align the ab initio models and gave us an average
envelope of 4E-BP free in solution displaying a normalized
spatial discrepancy (NSD) of 2.50 (Table 1). The
numerous independent runs yielded recurrent features
consistent with an extended three-branched shape.
Conceptually, a structure with three branches can only
be formed if there is a folding in the central region of
the disordered protein, consistent with the prediction of
a central structured region. This would imply that, in
solution, the central region of 4E-BP is to some extent
pre-structured, facilitating the interaction with eIF4E by
protecting the hydrophobic region containing the
eIF4E-binding site.
4E-BP compacts upon binding to eIF4E
This successful SAXS analysis of 4E-BP then led us to
determine the eIF4E/4E-BP complex structure using full
length recombinant 4E-BP. SAXS analysis of the complex
produced the scattering curve (Figure 2a), with the Kratky
proﬁle in the inset, consisting of an approximate bell-
shaped curve typical of a largely folded conformation
(24). The binding afﬁnities of homologous proteins
(non-phosphorylated 4E-BPs for human eIF4E) are high
Figure 1. Structure of 4E-BP free in solution. (a) Experimental SAXS
proﬁle of 4E-BP (green dots) ﬁtted by the scattering curves calculated
with the program DAMMIF (yellow). Inset: Kratky plot [I(q)q
2 versus
q] with a plateau illustrating speciﬁcally the unfolded nature of 4E-BP.
(b) Example of the most typical shape of 4E-BP, as obtained by
DAMMIF, shown in two orientations rotated by 180 .
Nucleic Acids Research,2011, Vol.39, No. 8 3499(estimated KD values of 10
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 9) (26), and suggest that,
after gel ﬁltration of the formed complex, we are not in
presence of an equilibrium between the free and the
complexed proteins in solution. Moreover, the calculated
molecular mass of the scattering particles of the complex,
derived from the experimental forward scattering intensity
I(0) that was measured (Table 1), is in total agreement
with the expected molecular mass, validating the fact
that only the complex is present in solution. Analysis of
the scattering curve in the low q region with the Guinier
approximation gave an Rg of 3.52nm with a maximal
distance (Dmax) of 12.1nm (Table 1). We ﬁrst controlled
that the Rg and Dmax of the complex were superior to the
ones we obtained for eIF4E (Rg Guinier= 2.23nm;
Dmax=6.8nm) (Table 1). We then compared these
values to the ones obtained from the scattering curve of
4E-BP free in solution. Rg and Dmax of the complex were
clearly inferior, thus demonstrating that the complex
eIF4E/4E-BP is much less extended than 4E-BP itself.
These results show that the 4E-BP in complex with eIF4E
ismorecompactthanfreeinsolutionandundergoespartial
refolding upon interaction with eIF4E. The overall
envelopes of the complex were calculated ab initio from
its scattering proﬁle using DAMMIF and subsequently
compared with the program DAMAVER that computes
the NSD value for the obtained shapes. The various calcu-
lations led to similar forms with an average of the
NSD values (1.40) signiﬁcantly lower than the average
found for 4E-BP free state (2.50) (Table 1), providing
additional evidence that 4E-BP undergoes a compaction
in the bound state. The recurrent shape of the complex
was composed of three modules (Figure 2b), one central
that always displays the same shape, and two others
with slightly different orientations relative to the central
Figure 2. Structure of 4E-BP bound to eIF4E in solution. (a) Experimental SAXS proﬁle of the complex 4E-BP/eIF4E (blue dots) ﬁtted by the
scattering curves calculated with the program DAMMIF (brown). Inset: Kratky plot [I(q)q
2 versus q] showing a typical proﬁl of a partially unfolded
protein. (b) Example of the most typical shape of the complex 4E-BP/eIF4E, as obtained by DAMMIF, shown in two orientations rotated by 180 .
(c) Example of the most typical shape of the complex 4E-BP/eIF4E displayed in a blue transparent surface representation, superimposed with the
crystal structure of eIF4E lacking the 30 amino acids on N-terminal (blue) and complexed with the 4E-BP peptide (red) (PDB number: 1WKW) (20).
The position of the N-terminal extremity has been determined in the Supplementary Figure S2. The red circle indicates the position of the extended
extremities of 4E-BP full-length. In cyan blue is displayed the average low resolution model for the free eIF4E.
3500 Nucleic Acids Research, 2011,Vol.39, No. 8shape in the different runs, characteristic of disordered
regions. The most typical shape of the complex obtained
with DAMMIF is illustrated in Figure 2b. We super-
imposed the crystal structure of eIF4E lacking the
N-terminal 30 residues fragment, complexed with a
4E-BP peptide (20) (Figure 2c), by rotation and translation
to ﬁt the envelope. The atomic structure of eIF4E
superimposed adequately and unambiguously with the
central module of the low-resolution model. The
N-terminal 30 residues fragment of eIF4E has never
been observed in the eIF4E crystal structure due to its
high ﬂexibility. Consequently, we determined that these
N-terminal residues constitute the adjacent module, using
SAXS data collected for recombinant full length eIF4E
free in solution (Supplementary Figure S2). The third
module (red circle, Figure 2c) therefore could not be
attributed to the crystal structure of eIF4E, and obviously
belonged to 4E-BP.
DISCUSSION
The intrinsically disordered nature of 4E-BP in solution
has hampered its full-length structure determination in the
past (6,7). We have applied an original structural method
which is receiving a growing interest, that gives access to
low-resolution structures of biological molecules in
solution (10). By comparing the experimental SAXS scat-
tering curves of eIF4E and 4E-BP alone with the one
for the puriﬁed eIF4E/4E-BP complex and by deriving
ab initio solution structures, we have gained new structural
insight into the determinant interactions for complex
formation.
The SAXS envelope obtained for the complex is
constituted by three modules, in which we localized
eIF4E. Given that the central peptide of 4E-BP is
known to interact with eIF4E at the dorsal molecular
surface of the eIF4E cap-binding pocket (6,20), we
conclude that the parts adjoining each side of the central
motif also interact along eIF4E and that the extremities
of 4E-BP form a disordered portion corresponding to
the third module of the SAXS envelope (Figure 2c).
Therefore, the interaction of eIF4E with the central
peptide and its adjoining sides causes the partial folding
of 4E-BP and supports the fact that 4E-BP reorganizes
and compacts when it interacts with eIF4E. In this
picture, 4E-BP, as an intrinsically disordered protein,
has the advantage to ‘catch’ more easily eIF4E with its
extended arm-like structures. Using its extremities to
embrace eIF4E, 4E-BP would then strengthen the inter-
action while forming a fuzzy complex (27): a ‘fuzzy
complex’ is constituted of at least one intrinsically un-
structured/disordered protein. The parts of the complex
that contribute productively to binding and function are
structurally ill-deﬁned, and cannot be described by a clas-
sical single conformational state. Comparing with
complexes of ordered and globular proteins, intrinsically
disordered proteins employ distinct molecular principles
of protein protein recognition and the interfaces are
more hydrophobic and often cover a much larger part of
the surfaces of the protein (28). Taking all together, our
data strongly suggest that the interaction between eIF4E
and 4E-BP not only relies on the central peptide, as cur-
rently thought, but that the binding footprint of 4E-BP
appears to be larger and should involve contacts outside
of this sequence.
A previous NMR study (8) has indirectly determined
the potential sites on eIF4E that are affected when
4E-BP binds eIF4E. From these data, we designed a
model of interaction between eIF4E and 4E-BP taking
into account the compaction of 4E-BP upon binding to
eIF4E (Figure 3). Following the potential 4E-BP binding
sites on eIF4E identiﬁed by NMR, we were able to add the
N- and C- terminal stretches of 4E-BP onto the crystal
structure of the peptide complex, designing residues until
4E-BP extremities reached the eIF4E boundaries (roughly
from residues 25 to 88, Figure 3a). We further observe that
this model ﬁts perfectly with the SAXS complex surface
(Figure 3b).
In addition, multiple sequence alignments of 4E-BP
sequences from distantly-related species (Supplementary
Figure S5) reveal that the amino acids from 30 to 86 are
highly conserved with >90% identity between the species.
The apparent evolutionary pressure towards conservation
of primary structure within these regions supports the
notion that not only the L-shaped central domain
[residues 47 66, (20)] but also its adjoining sides have a
functional signiﬁcance. Thus, these ﬂanking parts of the
central motif (residues 30 46 and 67 86) may provide a
physical link through dynamic contacts with eIF4E. In the
C-terminal extremity, only one or two residues are
conserved (105 107) apart from the mTOR-signaling
(TOS) (29) motif at the very end of the sequence. In
contrast, residues of the N-terminal region, plus the
RAIP motif (named after its sequence) (29), are mostly
conserved suggesting that the N-terminal extremity
would be more interesting for investigating potential
avidity hot spots involved in the interaction with eIF4E,
as suggested by Abiko et al. (30).
This new model of interaction helps to reinterpret data
that could not be explained by binding of the 4E-BP
central peptide alone to eIF4E. For instance, it could
explain why in presence of 4EGi-1 (9), 4E-BP still binds
to eIF4E while eIF4G cannot bind. Indeed, a NMR study
(31) showed that eIF4G establishes extensive contacts with
the normally disordered N-terminal extremity of eIF4E, in
addition to the binding of the consensus motif. In
contrast, our model of full-length 4E-BP with eIF4E
rather covers the structured part of eIF4E and does not
appear to interact with the disordered N-terminal part.
This is in agreement with the observation that there is
an apparent overlapping but non-identical binding site
of eIF4G and 4E-BPs (31).
The vision of a larger footprint brings also new insights
for the understanding of the association/dissociation of
the complex controlled by 4E-BP phosphorylation that
is not fully understood yet (5). Indeed, it was shown by
Oulhen et al. (5) that the phosphorylation of the following
sites, namely T37, T46, S65, T70 on 4E-BP, was necessary
but not sufﬁcient to prevent the association between
eIF4E and 4E-BP, contrary to what was currently
thought. Our model gives thus new leads to investigate
Nucleic Acids Research,2011, Vol.39, No. 8 3501potential modiﬁcations, well outside of the central motif,
that would participate and would be essential in the
release of 4E-BP from eIF4E.
As a crucial translational repressor, the demonstration
that unstructured free 4E-BP reorganizes subsequent to
eIF4E binding changes the current vision of the regulation
of the eIF4E/4E-BP complex formation and stabilization,
and gives new perspectives for the understanding of trans-
lational control.
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